Concepedia

Sarah P. McManaway

SP

4

Publications

97

Citations

4

H-Index

2014

Active since

Affiliations

University of Auckland(Current)

Maurice Wilkins Centre

Cancer Society of New Zealand

Sarah P. McManaway is an author at University of Auckland specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2014–2021

4

Publications

4

An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids

Xinjian Mao, Sarah P. McManaway, Jagdish K. Jaiswal et al. · PLoS Computational Biology · 2018 · 45 citations · Full text

, , +24

The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs

Francis W. Hunter, Jagdish K. Jaiswal, Daniel Hurley et al. · Biochemical Pharmacology · 2014 · 25 citations · Full text

, , +8

Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System

Abigail V. Sharrock, Sarah P. McManaway, Michelle H. Rich et al. · Frontiers in Pharmacology · 2021 · 16 citations · Full text

Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000

Xinjian Mao, Sarah P. McManaway, Jagdish K. Jaiswal et al. · Cancer Biology & Therapy · 2019 · 11 citations · Full text

Rows per page

1–4 of 4